King-Jones Heidy 4
4 · Spyre Therapeutics, Inc. · Filed Feb 2, 2024
Insider Transaction Report
Form 4
King-Jones Heidy
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2024-02-01+63,000→ 63,000 totalExercise: $25.86Exp: 2034-02-01→ Common Stock (63,000 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase 63,000 shares of the Issuer's common stock, which will vest in equal monthly installments over four years, subject to the Reporting Person's continued employment with the Issuer at each vesting date.